Pharmaceutical research and new drug development rely extensively on animal
research. The development of novel agents for intrathecal administration r
equires preclinical studies of toxic effects in an animal model, We have de
veloped a nonrodent animal model for this purpose.
Our sheep model:
1 Is an animal whose neural axis is similar to the human
2 Allows for the percutaneous placement of intrathecal catheters
3 Has minimal possibilities of infection because the infusion system is tot
ally implanted
4 Provides continuous infusion of the test agent
5 Generates behavioral, motor, neurological and histopathological informati
on so that safety guidelines can be established prior to preclinical studie
s.